الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>m-Methoxybenzamide

m-Methoxybenzamide (Synonyms: m-Anisamide, meta-Methoxybenzamide, NSC 28589, NSC 209527)

رقم الكتالوجGC47693

m-Methoxybenzamide (3-MBA) ، وهو مثبط لـ ADP-ribosyltransferase (ADPRTs) و PARP ، يمنع انقسام الخلايا في العصوية الرقيقة ، مما يؤدي إلى الفتيل وتحلل الخلايا في النهاية. يعزز m-Methoxybenzamide (3-MBA) نمو النبات في المختبر ، والتحول الدقيق ، وكفاءة التحول للبطاطس الزرقاء (Solanum tuberosum L. subsp. andigenum).

Products are for research use only. Not for human use. We do not sell to patients.

m-Methoxybenzamide التركيب الكيميائي

Cas No.: 5813-86-5

الحجم السعر المخزون الكميّة
5 g
83٫00
متوفر
10 g
160٫00
متوفر
25 g
378٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

m-Methoxybenzamide is an inhibitor of poly(ADP-ribose) polymerase (PARP; Ki = <2 µM).1 It also inhibits human placental ADP ribosyl transferase activity by 93% when used at a concentration of 100 µM.2 m-Methoxybenzamide (100, 200, and 300 mg/kg) increases the pain threshold in the paw pinch test in rats.3

1.Purnell, M.R., and Whish, W.J.Novel inhibitors of poly(ADP-ribose) synthetaseBiochem. J.185(3)775-777(1980) 2.Burtscher, H.J., Auer, B., Klocker, H., et al.Isolation of ADP-ribosyltransferase by affinity chromatographyAnal. Biochem.152(2)285-290(1986) 3.Sanders, R., Dill, R.E., Dorris, R.L., et al.Analgesic effects of 3-methoxybenzamide in ratsJ. Pharm. Pharmacol.41(4)268-269(1989)

مراجعات

Review for m-Methoxybenzamide

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for m-Methoxybenzamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.